# A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers

> **NCT00850681** · PHASE1 · COMPLETED · sponsor: **Peplin** · enrollment: 50 (estimated)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** PEP005 (ingenol mebutate) Gel

## Key facts

- **NCT ID:** NCT00850681
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00850681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00850681, "A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00850681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*